Pemetrexed is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc.. The primary component is Pemetrexed Disodium.
| Product ID | 0781-3519_4dd3bb2b-a3c3-4ede-bfdf-aeac922bcfde |
| NDC | 0781-3519 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pemetrexed |
| Generic Name | Pemetrexed Disodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-06-08 |
| Marketing Category | NDA / |
| Application Number | NDA214657 |
| Labeler Name | Sandoz Inc. |
| Substance Name | PEMETREXED DISODIUM |
| Active Ingredient Strength | 500 mg/20mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-06-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0338-0720 | PEMETREXED | PEMETREXED |
| 0338-0722 | PEMETREXED | PEMETREXED |
| 0409-1045 | PEMETREXED | PEMETREXED |
| 0409-1060 | Pemetrexed | Pemetrexed |
| 0409-1061 | Pemetrexed | Pemetrexed |
| 0409-1062 | Pemetrexed | Pemetrexed |
| 0409-2188 | PEMETREXED | PEMETREXED |
| 0409-3532 | PEMETREXED | PEMETREXED |
| 0480-4514 | Pemetrexed | Pemetrexed |
| 0480-4515 | Pemetrexed | Pemetrexed |
| 0480-4516 | Pemetrexed | Pemetrexed |
| 0781-3518 | Pemetrexed | Pemetrexed disodium |
| 0781-3519 | Pemetrexed | Pemetrexed disodium |
| 0781-3520 | Pemetrexed | Pemetrexed disodium |
| 16729-229 | Pemetrexed | Pemetrexed |
| 16729-230 | Pemetrexed | Pemetrexed |
| 16729-244 | Pemetrexed | Pemetrexed |
| 16729-522 | Pemetrexed | Pemetrexed disodium |
| 0002-7623 | Alimta | Pemetrexed disodium |
| 0002-7640 | Alimta | Pemetrexed disodium |